论文部分内容阅读
目的 :分析慢性阻塞性肺疾病急性加重期应用喘可治联合沙美特罗替卡松粉吸入剂治疗的效果。方法 :随机选择2014年12月-2016年11月在本院接受治疗的慢性阻塞性肺疾病急性加重期患者84例参与研究,随机平均分成2组,对照组利用喘可治氧气雾化吸入治疗,观察组选择喘可治联合沙美特罗替卡松粉吸入剂治疗,比较两组效果。结果 :观察组治疗后肺功能各项指标FVC、FEV1.0、FEV1.0/FVC、MVV以及血气各项指标PaO2、PaCO2、SaO2均优于对照组。结论 :喘可治联合沙美特罗替卡松粉吸入剂治疗慢性阻塞性肺疾病急性加重期患者能够提高治疗效果,更显著改善临床症状,值得推广。
OBJECTIVE: To analyze the effect of chuankezhi combined with salmeterol and fluticasone powder inhaler on acute exacerbation of chronic obstructive pulmonary disease. Methods: Eighty-four patients with acute exacerbation of chronic obstructive pulmonary disease who were treated in our hospital from December 2014 to November 2016 were randomly selected and divided into two groups randomly. The patients in the control group were treated with asthma inhalation therapy , Observation group choose asthma treatment combined with salmeterol fluticasone powder inhalation treatment, the two groups were compared. Results: After treatment, FVC, FEV1.0, FEV1.0 / FVC, MVV, PaO2, PaCO2 and SaO2 in lung function of the observation group were all better than those in the control group. Conclusion: Treatment of patients with acute exacerbation of chronic obstructive pulmonary disease with asthma therapy combined with salmeterol and fluticasone may improve the therapeutic effect, but also significantly improve the clinical symptoms and should be promoted.